The Beauty Health Company (NASDAQ:SKIN) Given Consensus Rating of “Reduce” by Analysts

Shares of The Beauty Health Company (NASDAQ:SKIN) have been assigned an average recommendation of “Reduce” from the twelve research firms that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $2.46.

Several equities research analysts have recently weighed in on SKIN shares. Piper Sandler reaffirmed an “underweight” rating and issued a $1.00 target price (down previously from $1.50) on shares of Beauty Health in a research report on Friday, August 9th. Stifel Nicolaus dropped their price objective on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a research note on Friday, July 26th. Finally, Canaccord Genuity Group lowered their price target on shares of Beauty Health from $2.00 to $1.25 and set a “hold” rating for the company in a report on Monday, August 12th.

Beauty Health Price Performance

SKIN stock opened at $1.64 on Wednesday. The company has a market cap of $202.76 million, a PE ratio of -2.34 and a beta of 0.95. The company has a current ratio of 6.49, a quick ratio of 5.47 and a debt-to-equity ratio of 7.96. The stock has a 50-day moving average price of $1.65 and a two-hundred day moving average price of $2.51. Beauty Health has a 12-month low of $0.91 and a 12-month high of $6.79.

Beauty Health (NASDAQ:SKIN) last posted its earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). The business had revenue of $90.60 million for the quarter, compared to analyst estimates of $98.46 million. Beauty Health had a negative return on equity of 4.57% and a negative net margin of 22.86%. As a group, research analysts predict that Beauty Health will post -0.2 EPS for the current year.

Insider Activity

In other news, Chairman Brent L. Saunders bought 40,450 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was bought at an average price of $1.08 per share, for a total transaction of $43,686.00. Following the transaction, the chairman now owns 5,921,769 shares in the company, valued at $6,395,510.52. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 41.00% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Aigen Investment Management LP boosted its position in Beauty Health by 88.7% during the 4th quarter. Aigen Investment Management LP now owns 31,865 shares of the company’s stock valued at $99,000 after purchasing an additional 14,974 shares during the period. Sierra Summit Advisors LLC acquired a new stake in shares of Beauty Health in the 4th quarter worth about $856,000. 180 Wealth Advisors LLC lifted its position in Beauty Health by 14.9% in the 1st quarter. 180 Wealth Advisors LLC now owns 81,285 shares of the company’s stock valued at $361,000 after purchasing an additional 10,566 shares during the last quarter. HighMark Wealth Management LLC acquired a new position in Beauty Health during the 1st quarter valued at about $31,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Beauty Health in the first quarter valued at approximately $200,000. 93.26% of the stock is owned by institutional investors and hedge funds.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.